{
    "id": "professional_medicine-221",
    "question": "A 25-year-old man is brought to the emergency department because of a 6-day history of fever, severe muscle pain, and diffuse, painful swelling of his neck, underarms, and groin area. The symptoms began after returning from a camping trip in New Mexico. He appears ill and lethargic and can barely answer questions. His temperature is 39.2\u00b0C (102.5\u00b0F), pulse is 120/min, respirations are 22/min, and blood pressure is 110/70 mm Hg. Physical examination shows generalized scattered black maculae. Examination of the right upper extremity shows an erythematous, solid, tender mass on the underside of the upper extremity just above the elbow; the mass is draining blood and necrotic material. The most effective antibiotic for this patient\u2019s disorder will interfere with which of the following cellular processes or enzymes?",
    "options": {
        "A": "DNA helicase",
        "B": "Glucuronosyltransferase",
        "C": "Proteasomal degradation",
        "D": "Ribosomal assembly"
    },
    "answer": "D",
    "predict": "To approach this question, let's analyze the symptoms and physical examination findings presented in the scenario. The patient presents with fever, severe muscle pain, diffuse, painful swelling of the neck, underarms, and groin area, which began after returning from a camping trip in New Mexico. The physical examination findings include scattered black maculae, an erythematous, solid, tender mass on the underside of the upper extremity just above the elbow that is draining blood and necrotic material. These symptoms are highly suggestive of cutaneous anthrax, a bacterial infection caused by Bacillus anthracis. Cutaneous anthrax is characterized by a skin lesion that can progress from a painless, ulcerative lesion to a painful, black eschar. The presence of necrotic material draining from the lesion is also consistent with this diagnosis. Given the effective treatment for cutaneous anthrax, we need to determine which cellular process or enzyme the antibiotic should target. A. DNA helicase: This enzyme is involved in unwinding double-stranded DNA during replication and transcription. It is not the primary target for antibiotics used to treat cutaneous anthrax. B. Glucuronosyltransferase: This enzyme is involved in the metabolism of glucuronic acid, a conjugation reaction that is not directly relevant to the treatment of cutaneous anthrax. C. Proteasomal degradation: This process is involved in the breakdown of proteins within cells. While some antibiotics do target protein synthesis, the primary mechanism of action of antibiotics used to treat cutaneous anthrax is not through proteasomal degradation. D. Ribosomal assembly: Antibiotics such as doxycycline, ciprofloxacin, and amoxicillin are effective against cutaneous anthrax by inhibiting protein synthesis. They bind to the 30S ribosomal subunit of the bacterial ribosome, which is essential for the assembly of the bacterial protein synthesis machinery. Therefore, the most effective antibiotic for this patient's disorder, which is cutaneous anthrax, will interfere with ribosomal assembly. {\"step_by_step_thinking\": \"The patient presents with symptoms and physical examination findings consistent with cutaneous anthrax. The most effective antibiotic for this condition is doxycycline, which targets the 30S ribosomal subunit of the bacterial ribosome, interfering with protein synthesis.\", \"answer_choice\": \"D\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 47.90439772605896
}